PLEASANTON, Calif., Aug. 15, 2013 (GLOBE NEWSWIRE) -- ZELTIQ®, (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, will host an investor and analyst day in a Midtown Manhattan Hotel in New York, NY on September 17th, 2013 from 10:00 a.m. ET to 12:00 p.m. ET. The event will highlight the Company's technology and growth strategy and will include an interactive physician panel who will discuss CoolSculpting® and the market for non-invasive body sculpting.
| Event: ZELTIQ Investor Day |
| Date: September 17, 2013 |
| Time: 10:00 a.m. ET to 12:00 p.m. ET. |
| Location: TBD / Midtown Manhattan, New York, NY |
The Company will issue an additional press release with further details regarding the event.
An audio web cast of the presentation will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.
About ZELTIQ®
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.